Corneal thickness and glaucoma medications.
Mehdizadeh
Morteza
M
Jamshidian-Tehrani
Mansoureh
M
Nowroozzadeh
Mohammad H
MH
D000577:Amides / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000069580:Bimatoprost; D002940:Circadian Rhythm / Q000187:drug effects* / Q000502:physiology; D003008:Cloprostenol / Q000008:administration & dosage / Q000031:analogs & derivatives; D003315:Cornea / Q000187:drug effects / Q000473:pathology*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D017889:Exfoliation Syndrome / Q000188:drug therapy / Q000503:physiopathology; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects* / Q000502:physiology; D000077338:Latanoprost; D009798:Ocular Hypertension / Q000188:drug therapy / Q000503:physiopathology; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D016037:Single-Blind Method; D013449:Sulfonamides / Q000008:administration & dosage; D013876:Thiophenes / Q000008:administration & dosage; D013999:Timolol / Q000008:administration & dosage; D014065:Tonometry, Ocular; D000069557:Travoprost; D016896:Treatment Outcome
D000577:Amides; D000959:Antihypertensive Agents; D004338:Drug Combinations; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic; D013449:Sulfonamides; D013876:Thiophenes; D003008:Cloprostenol; D000077338:Latanoprost; D013999:Timolol; C062765:dorzolamide; D000069580:Bimatoprost; D000069557:Travoprost